The August 2025 recall spotlights four previously released episodes on topics related to dementia diagnosis. The episode begins with Dr. Amy Brodtmann discussing the complexities of diagnosing frontotemporal dementia in clinical practice. Next, Dr. Joseph Therriault delves into the use of plasma biomarkers in diagnosing Alzheimer disease. In the third episode, Dr. Trey Bateman discusses the growing significance of blood-based biomarkers in Alzheimer disease. The episode concludes with Dr. Gregg Day discussing the clinical implications of using plasma biomarkers in real-world patient care.

Podcast links: 

Frontotemporal Dementia Differential Diagnosis in Clinical Practice

Diagnosis of Alzheimer Disease Using Plasma Biomarkers

Understanding Blood-Based Biomarkers in Alzheimer Disease

Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic

Article links: 

Frontotemporal Dementia Differential Diagnosis in Clinical Practice

Diagnosis of Alzheimer’s Disease Using Plasma Biomarkers Adjusted to Clinical Probability

Diagnostic Performance of Plasma p-tau217 and Aβ42/40 Biomarkers in the Outpatient Memory Clinic

Disclosures can be found at Neurology.org. 

Dr. Kathryn Krulisky talks with Dr. Jordan Garris about educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. 

Read the related article in Neurology® Education. 

Disclosures can be found at Neurology.org. 

Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. 

Read the related article in The New England Journal of Medicine. 

Disclosures can be found at Neurology.org. 

Dr. Jason Crowell talks with Dr. Daniel Weintraub about clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. 

Read the related article in Neurology®. 

Listen to the related podcast episode with Dr. Jeff Ratliff. 

Disclosures can be found at Neurology.org. 

Dr. Dan Ackerman talks with Dr. James Ernest Siegler about the complexities of treating ESUS and emphasizes the importance of personalized treatment approaches based on individual patient factors. 

Read the related article in Neurology®.

Disclosures can be found at Neurology.org. 

Dr. Trey Bateman talks with Dr. Gregg Day about the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care. 

Read the related article in Alzheimer's & Dementia. 

Disclosures can be found at Neurology.org. 

Dr. Justin Abbatemarco talks with Dr. Eric L. Voorn about the efficacy of combined personalized home-based aerobic exercise and coaching on physical fitness in people with neuromuscular diseases, compared with usual care. 

Read the related article in Neurology®.

Read the additional article that was referenced. 

Disclosures can be found at Neurology.org. 

Dr. Jeff Ratliff talks with Dr. Claire Henchcliffe about the study's key findings while emphasizing the importance of educating patients about stem cell therapies and the ongoing advancements in this field. 

Read the related article in Nature.

Disclosures can be found at Neurology.org. 

Dr. Jason Crowell talks with Dr. Brian E. Emmert about the results from the 2022 AAN Resident Survey and explore areas for future improvement. 

Read the related article in Neurology® Education. 

Disclosures can be found at Neurology.org. 

Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. 

Disclosures can be found at Neurology.org.